These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 410101)

  • 21. Dog MHC class I antigens contain beta 2-microglobulin.
    van der Feltz MJ; van der Korput HA; Giphart MJ; Westbroek DL
    Exp Clin Immunogenet; 1984; 1(1):56-9. PubMed ID: 6401141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recognition of GIX-linked minor histocompatibility antigens by H-2-restricted cytotoxic T lymphocytes from C57BL/6-GIX+ mice: an approach to mapping the genes controlling GIX.
    Green WR
    J Immunol; 1982 Feb; 128(2):920-5. PubMed ID: 6172516
    [No Abstract]   [Full Text] [Related]  

  • 23. A deletion in a rat major histocompatibility complex class I gene is linked to the absence of beta 2-microglobulin-containing serum molecules.
    Björck L; Kryspin-Sörensen I; Dyrberg T; Lernmark A; Kastern W
    Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5630-3. PubMed ID: 3016711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytotoxic t-cell response to histocompatibility antigens: the role of H-2.
    Bevan MJ
    Cold Spring Harb Symp Quant Biol; 1977; 41 Pt 2():519-27. PubMed ID: 302175
    [No Abstract]   [Full Text] [Related]  

  • 25. Transplantation in miniature swine. XII. N-terminal sequences of class I histocompatibility antigens (SLA) and beta 2-microglobulin.
    Metzger JJ; Lunney JK; Sachs DH; Rudikoff S
    J Immunol; 1982 Aug; 129(2):716-21. PubMed ID: 6177778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Organization of RT1-DOa and RT1-DOb loci.
    Kakinuma M; Tang WR; Arimura Y; Koda T; Kishi M
    Transplant Proc; 1997 May; 29(3):1670. PubMed ID: 9142226
    [No Abstract]   [Full Text] [Related]  

  • 27. Cytotoxic T-cell responses to H-Y: correlation with the rejection of syngeneic male skin grafts.
    Hurme M; Chandler PR; Hetherington CM; Simpson E
    J Exp Med; 1978 Mar; 147(3):768-75. PubMed ID: 416166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure and viral interactions of H-2 antigens.
    Cunningham BA; Reske K; Milner RJ; Schrader JW; Ziffer JA
    Birth Defects Orig Artic Ser; 1978; 14(2):203-16. PubMed ID: 76484
    [No Abstract]   [Full Text] [Related]  

  • 29. Absence of allogeneic restriction in human T-cell-mediated cytotoxicity to Epstein-Barr virus-infected target cells. Demonstration of an HLA-linked control at the effector level.
    Lipinski M; Fridman WH; Tursz T; Vincent C; Pious D; Fellous M
    J Exp Med; 1979 Dec; 150(6):1310-22. PubMed ID: 229186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human T cell clones use a CD3-associated surface antigen recognition structure to exhibit both NK-like and allogeneic cytotoxic reactivity.
    David V; Bourge JF; Guglielmi P; Mathieu-Mahul D; Degos L; Bensussan A
    J Immunol; 1987 May; 138(9):2831-6. PubMed ID: 3106490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Major histocompatibility complex class I-specific and -restricted killing of beta 2-microglobulin-deficient cells by CD8+ cytotoxic T lymphocytes.
    Glas R; Franksson L; Ohlén C; Höglund P; Koller B; Ljunggren HG; Kärre K
    Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11381-5. PubMed ID: 1454824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relating the structure of major transplantation antigens to immune function.
    Duran LW; Pease LR
    Transplantation; 1986 Mar; 41(3):279-85. PubMed ID: 3082046
    [No Abstract]   [Full Text] [Related]  

  • 33. Construction, expression and recognition of an H-2 molecule lacking its carboxyl terminus.
    Murre C; Reiss CS; Bernabeu C; Chen LB; Burakoff SJ; Seidman JG
    Nature; 1984 Feb 2-8; 307(5950):432-6. PubMed ID: 6363940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serological identification of HL-A-linked human "Ia-type" antigens.
    Jones EA; Goodfellow PN; Bodmer JG; Bodmer WF
    Nature; 1975 Aug; 256(5519):651-2. PubMed ID: 1097943
    [No Abstract]   [Full Text] [Related]  

  • 35. Structural studies of H-2 and TL alloantigens.
    Uhr JW; Vitetta ES; Klein J; Poulik MD; Klapper DG; Capra JD
    Cold Spring Harb Symp Quant Biol; 1977; 41 Pt 1():363-8. PubMed ID: 70314
    [No Abstract]   [Full Text] [Related]  

  • 36. Reassociation with beta 2-microglobulin is necessary for Kb class I major histocompatibility complex binding of exogenous peptides.
    Rock KL; Rothstein LE; Gamble SR; Benacerraf B
    Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7517-21. PubMed ID: 2217182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic control of autoimmune disease and immune responsiveness and the relationship to aging.
    Greenberg LJ; Yunis EJ
    Birth Defects Orig Artic Ser; 1978; 14(1):249-60. PubMed ID: 415770
    [No Abstract]   [Full Text] [Related]  

  • 38. Highly lytic CD8+, alpha beta T-cell receptor cytotoxic T cells with major histocompatibility complex (MHC) class I antigen-directed cytotoxicity in beta 2-microglobulin, MHC class I-deficient mice.
    Apasov S; Sitkovsky M
    Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2837-41. PubMed ID: 8464897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolonged survival of heart allografts in rats treated with antisera to beta2-microglobulin.
    Bjorck L; Konrad P; Husberg B; Berggard I
    Transplantation; 1977 Apr; 23(4):383-6. PubMed ID: 68562
    [No Abstract]   [Full Text] [Related]  

  • 40. The major histocompatibility complex in man: biological and molecular approaches.
    Ferrone S; Pellegrino MA; Reisfeld RA
    Prog Allergy; 1976; 21():114-77. PubMed ID: 63954
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.